Synthetic Inhibitors of Matrix Metalloproteinases
- 1 January 1998
- book chapter
- Published by Elsevier
Abstract
No abstract availableThis publication has 52 references indexed in Scilit:
- Conversion of highly malignant colon cancer from an aggressive to a controlled disease by oral administration of a metalloproteinase inhibitorClinical & Experimental Metastasis, 1997
- High levels of stromelysin-3 correlate with poor prognosis in patients with breast carcinomaInternational Journal of Cancer, 1996
- Patent Update Oncologic, Endocrine & Metabolic: Oncologic, Endocrine & Metabolic: Recent advances in the field of matrix metalloproteinase inhibitorsExpert Opinion on Therapeutic Patents, 1996
- Recent advances in matrix metalloproteinase inhibitor researchDrug Discovery Today, 1996
- Metalloproteinase inhibitors and the prevention of connective tissue breakdownPharmacology & Therapeutics, 1996
- Matrix metalloproteinase inhibition: A review of anti-tumour activityAnnals of Oncology, 1995
- Matrix metalloproteinases degrade myelin basic proteinNeuroscience Letters, 1995
- Inhibition of the metastatic spread and growth of B16‐BL6 murine melanoma by a synthetic matrix metalloproteinase inhibitorInternational Journal of Cancer, 1994
- Stromelysin-3 in stromal tissue as a control factor in breast cancer behaviorCancer, 1994
- Inhibition of Ovulation in the Perfused Rat Ovary by the Synthetic Collagenase Inhibitor SC 444631Biology of Reproduction, 1991